{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Uwe E. Reinhardt is an economics professor at Princeton.", "headline": {"main": "Is Medicare Raising Prices for the Privately Insured?", "kicker": "Economix"}, "abstract": "Some claim that Medicare underpays hospitals, leaving private insurers to pick up the difference. An economist explains why many experts dispute this narrative.", "print_page": null, "word_count": 907, "_id": "4fd398318eb7c8105d8d2386", "snippet": "Some claim that Medicare underpays hospitals, leaving private insurers to pick up the difference. An economist explains why many experts dispute this narrative.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://economix.blogs.nytimes.com/2009/10/16/is-medicare-raising-prices-for-the-privately-insured/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"firstname": "Uwe", "middlename": "E.", "lastname": "REINHARDT", "rank": 1, "role": "reported", "organization": ""}], "original": "By UWE E. REINHARDT"}, "document_type": "blogpost", "pub_date": "2009-10-16T06:24:22Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Behind closed doors, lawmakers hotly debated a public option and a Medicare bill.", "headline": {"main": "Democrats Address Their Own Rifts on Health Care", "print_headline": "Democrats Address Their Own Rifts on Health Care"}, "abstract": null, "print_page": "18", "word_count": "840", "_id": "5457570879881005d1b84e03", "snippet": "Behind closed doors, lawmakers hotly debated a public option and a Medicare bill.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/10/16/health/policy/16health.html", "multimedia": [{"width": 75, "url": "images/2009/10/16/us/Health_75.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2009/10/16/us/Health_75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Money & Policy", "keywords": [{"rank": "1", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Reform and Reorganization", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Democratic Party", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "United States Politics and Government", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Law and Legislation", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "David", "rank": 1}], "original": "By DAVID M. HERSZENHORN and ROBERT PEAR"}, "document_type": "article", "pub_date": "2009-10-16T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial", "lead_paragraph": "The report released by the lobbying organization America\u2019s Health Insurance Plans, or AHIP, was dismissed by experts as a hatchet job, but it may have led to a better bill.", "headline": {"main": "A Hatchet Job So Bad It\u2019s Good", "print_headline": "A Hatchet Job So Bad It\u2019s Good", "content_kicker": "Op-Ed Columnist"}, "abstract": null, "print_page": "27", "word_count": "782", "_id": "545755e979881005d1b84de5", "snippet": "The report released by the lobbying organization America\u2019s Health Insurance Plans, or AHIP, was dismissed by experts as a hatchet job, but it may have led to a better bill.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/10/16/opinion/16krugman.html", "multimedia": [{"width": 190, "url": "images/2014/10/30/opinion/krugman-new-1114/krugman-new-1114-thumbWide.jpg", "height": 126, "subtype": "wide", "legacy": {"wide": "images/2014/10/30/opinion/krugman-new-1114/krugman-new-1114-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"width": 600, "url": "images/2014/10/30/opinion/krugman-new-1114/krugman-new-1114-articleLarge.jpg", "height": 900, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2014/10/30/opinion/krugman-new-1114/krugman-new-1114-articleLarge.jpg", "xlargeheight": "900"}, "type": "image"}, {"width": 75, "url": "images/2006/04/02/opinion/ts-krugman-75.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2006/04/02/opinion/ts-krugman-75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "America's Health Insurance Plans", "name": "organizations"}, {"rank": "2", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Reform and Reorganization", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Lobbying and Lobbyists", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Medicare", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Senate Committee on Finance", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Paul", "rank": 1, "lastname": "KRUGMAN"}], "original": "By PAUL KRUGMAN"}, "document_type": "article", "pub_date": "2009-10-16T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Congressional Republicans, though vulnerable to criticism that they have become little more than obstructionists, voice confidence that the politics are on their side.", "headline": {"main": "In Saying No, G.O.P. Sees More Pros Than Cons", "kicker": "Political Memo", "print_headline": "In Saying No, G.O.P. Sees More Pros Than Cons", "content_kicker": "Political Memo"}, "abstract": null, "print_page": "18", "word_count": "966", "_id": "5457575279881005d1b84e08", "snippet": "Congressional Republicans, though vulnerable to criticism that they have become little more than obstructionists, voice confidence that the politics are on their side.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/10/16/us/politics/16memo.html", "multimedia": [], "subsection_name": "Politics", "keywords": [{"rank": "1", "is_major": "N", "value": "United States Politics and Government", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Republican Party", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Reform and Reorganization", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Polls and Public Opinion", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Law and Legislation", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Subprime Mortgage Crisis", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Jackie", "rank": 1, "lastname": "CALMES"}], "original": "By JACKIE CALMES"}, "document_type": "article", "pub_date": "2009-10-16T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Metro", "lead_paragraph": "Despite the governor\u2019s warning of a current $3 billion deficit, his proposals were met with indifference in the State Senate.", "headline": {"seo": "Paterson Proposes Billions in Albany Spending Cuts to Balance Budget", "main": "Paterson Proposes Cuts to Close Deficit", "print_headline": "Paterson Proposes Cuts Of Billions in Spending"}, "abstract": null, "print_page": "23", "word_count": "1019", "_id": "5457564f79881005d1b84df3", "snippet": "Despite the governor\u2019s warning of a current $3 billion deficit, his proposals were met with indifference in the State Senate.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/10/16/nyregion/16budget.html", "multimedia": [{"subtype": "xlarge", "url": "images/2009/10/16/nyregion/16budget_600.jpg", "height": 358, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2009/10/16/nyregion/16budget_600.jpg", "xlargeheight": "358"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Budgets and Budgeting", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "New York State", "is_major": "N", "rank": "2", "name": "glocations"}, {"value": "Paterson, David A", "is_major": "N", "rank": "3", "name": "persons"}, {"value": "State Legislatures", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Metropolitan Transportation Authority", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Politics and Government", "is_major": "N", "rank": "6", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Danny", "lastname": "HAKIM"}], "original": "By DANNY HAKIM"}, "document_type": "article", "pub_date": "2009-10-16T00:00:00Z", "section_name": "N.Y. / Region"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The sustainable growth rate is a formula set by law for reimbursing doctors for treating patients covered by Medicare as part of an effort to control the steep rise in Medicare costs. Because of quirks in the formula, doctors have faced the prospect of severe reductions and Congress has stepped in repeatedly to prevent those cuts by enacting laws now known as the annual ''doc fix.'' Under current law, doctors face cuts of 21.5 percent in January and about 5.5 percent in each of the next four years.", "headline": {"main": "Sustainable Growth Rate", "kicker": "THE BASICS"}, "abstract": "Definition of sustainable growth rate, as formula set by law, for reimbursing doctors for treating patients covered by Medicare (S)", "print_page": "18", "word_count": 90, "_id": "4fd28c9d8eb7c8105d861979", "snippet": "The sustainable growth rate is a formula set by law for reimbursing doctors for treating patients covered by Medicare as part of an effort to control the steep rise in Medicare costs. Because of quirks in the formula, doctors have faced the prospect...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9907E6DE1E30F935A25753C1A96F9C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": null, "document_type": "article", "pub_date": "2009-10-16T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "One way Congress hopes to lower health care spending is by authorizing ''biosimilars.'' Those, essentially, would be generic versions of biotechnology drugs, medicines, like the cancer drug Avastin, that currently can cost tens of thousands of dollars a year. But a commentary published online this week by The New England Journal of Medicine says the current provisions in the health care legislation would do little to reduce prices of such drugs. That is because the new rules would not allow the copycat drugs to be sold until the original biotechnology drug had been on the market for 12 years. Such a delay, the authors argue, would discourage would-be competitors.", "headline": {"main": "Undermining an Argument", "kicker": "GENERIC DRUGS"}, "abstract": "Commentary published online by New England Journal of Medicine says current provisions in health care legislation would do little to reduce prices of biosimilars, generic versions of costly biotechnology drugs (S)", "print_page": "18", "word_count": 237, "_id": "4fd28c9d8eb7c8105d861969", "snippet": "One way Congress hopes to lower health care spending is by authorizing ''biosimilars.'' Those, essentially, would be generic versions of biotechnology drugs, medicines, like the cancer drug Avastin, that currently can cost tens of thousands of...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9F01E3D71639F935A25753C1A96F9C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "NEW ENGLAND JOURNAL OF MEDICINE"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2009-10-16T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "When does it make sense to spend more on medical care? Even as Congress aims to reduce the nation's Medicare spending, a new study underscores the challenges in determining which spending is wasteful and which is warranted.", "headline": {"main": "Spending More on Care", "kicker": "THE RESEARCH"}, "abstract": "Study by researchers from six California medical centers, published online in Circulation: Cardiovascular Quality and Outcomes, sees better survival rates of Medicare patients with heart failure at hospitals that spend more; photo (S)", "print_page": "18", "word_count": 244, "_id": "4fd274b38eb7c8105d833bf9", "snippet": "When does it make sense to spend more on medical care?      Even as Congress aims to reduce the nation's Medicare spending, a new study underscores the challenges in determining which spending is wasteful and which is warranted.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9F02E1DA1639F935A25753C1A96F9C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "CALIFORNIA"}, {"name": "organizations", "value": "CIRCULATION: CARDIOVASCULAR QUALITY AND OUTCOMES"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}, {"name": "subject", "value": "HOSPITALS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Reed", "rank": 1, "lastname": "ABELSON"}], "original": "By REED ABELSON"}, "document_type": "article", "pub_date": "2009-10-16T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Two Senate versions of health care legislation. Three in the House. And President Obama is still hoping to sign a final health bill into law by Christmas. As Congress heads toward floor debates on the effort to overhaul the nation's health care system, the Prescriptions blog introduces a new feature: Checkpoint, a frequently updated status report on the health care debate in Washington and beyond.", "headline": {"main": "Where Things Stand"}, "abstract": "Prescriptions blog, as Congress heads toward floor debates on health care overhaul, introduces new feature: Checkpoint, which is frequently updated status report on debate in Washington and beyond; photo (M)", "print_page": "18", "word_count": 374, "_id": "4fd28c9d8eb7c8105d86196d", "snippet": "Two Senate versions of health care legislation. Three in the House. And President Obama is still hoping to sign a final health bill into law by Christmas.      As Congress heads toward floor debates on the effort to overhaul the nation's health care...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9803E1D71639F935A25753C1A96F9C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By DAVID M. HERSZENHORN"}, "document_type": "article", "pub_date": "2009-10-16T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "If you are one of the roughly 160 million Americans who have health insurance through an employer-sponsored plan, this post is not necessarily for you. Feel free to click and move on.", "headline": {"main": "Another Public Option (but Probably Not for You)", "kicker": "Prescriptions"}, "abstract": "Senate Democrats launch yet another trial balloon for the public option.", "print_page": null, "word_count": 1151, "_id": "4fd397418eb7c8105d8cfc84", "snippet": "Senate Democrats launch yet another trial balloon for the public option.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://prescriptions.blogs.nytimes.com/2009/10/15/another-public-option-but-still-not-for-you/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By DAVID M. HERSZENHORN"}, "document_type": "blogpost", "pub_date": "2009-10-15T19:58:46Z", "section_name": "Health"}], "meta": {"hits": 86, "offset": 60, "time": 51}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}